Livongo Health, a company focused on aiding those with chronic conditions, filed for a $100 million IPO on 6/28/19. The initial filing does not specify the number of shares to be offered. The... read more
Livongo Health, a company focused on aiding those with chronic conditions, filed for a $100 million IPO on 6/28/19. The initial filing does not specify the number of shares to be offered. The... read more
Castle Biosciences Filed the paperwork on 6/26/19 for their $57 Million IPO. The commercial stage company provides diagnostic and prognostic test for dermatologic cancers. Castle intends to... read more
Adaptive updated their IPO filing on 6/26/19 and raised their potential raise to $327 million from $230 million listed in their original filing. The company currently offers tools for monitoring... read more
Vesalius Biocapital III ('Vesalius'), a specialist life sciences venture capital investor, announced on 6/25/19 the final close of the VBC III fund securing EUR 120 million of equity commitments.... read more
